News
RadiQual Surgery: winner of the Venture Challenge Fall 2016
RadiQual Surgery has developed a worldwide unique product called Logi-Knife that enables surgeons to make use of high quality diagnostic imaging data for real-time 3D surgical navigation during their surgical procedures. Using Logi-Knife, surgeons are able to perform the perfect cut to cure cancer.
Building future Life Sciences business leaders
From interest in entrepreneurship, to innovative ideas, serious business cases and global scaling up: the Life Sciences & Health sector offers educational and coaching programmes for every stage in your career. Please take a look at the roadmap.Report on joint Human Capital Agenda 2016-2020
The report illustrates the results and collaboration between the nine different top sectors.Proposal for FET Flagship on Biofabrication for Regenerative Medicine
This FET Flagship proposal contains a statement on the clustering of health topics in biofabrication for regenerative medicine. Related to the following topics: Human Printing Era (HOPE), organ-on-chip technology, European initiative for regenerative medicine, and sensory restoration.Dutch Healthcare system higly ranked in International Health Policy Survey
Amerikaanse denktank The Commonwalth Fund (CWF) legt Westerse landen langs de meetlat. En wederom scoort de Nederlandse zorg hoog in een internationaal onderzoek.Lygature opens new office at Utrecht Innovation hub
Vandaag opent Lygature haar nieuwe werkomgeving in Utrecht. Lygature, het resultaat van de fusie tussen CTMM en TI Pharma, is de eerste bewoner van de JIM: de Jaarbeurs Innovation Mile. De opening wordt verzorgd door de burgemeester van Utrecht, Jan van Zanen, en David Pappie, directeur topsectoren van het Ministerie van Economische Zaken.MyLife Technologies secures new growth capital
A consortium of informal investors has invested 0.5 million € in MyLife Technologies, a med tech company developing dermal delivery solutions based on its platform technology of ceramic nano-porous MicroNeedle Arrays (npMNA).AdAlta Licenses Alzheimer's Disease-Specific Shark Antibodies to Crossbeta Biosciences for Therapeutic and Diagnostic Development
AdAlta Limited, a biotechnology company specialising in the discovery and development of protein-based therapeutics, and Crossbeta Biosciences, a biotechnology company with unique technology for therapeutic and diagnostic use in neurodegenerative disorders, announced their commercialisation agreement.Mucosis Initiates First-in-Human Study of SynGEM, a Needle-Free Nasal Spray RSV Vaccine
Mucosis, a clinical stage biotechnology company using a proprietary technology platform to develop next-generation and needle-free human vaccines for infectious diseases, announces the start of a first-in-human study of its intranasal Respiratory Syncytial Virus (RSV) vaccine candidate, SynGEM, at Imperial College London’s Clinical Research Facility.Create Health at Drive Festival: Partnerships in design and healthcare
Hoe creëer je zorginnovaties met impact? Lees hier het verslag naar van het Drive Festival waar Create Health presenteerde over partnerschappen in design en healthcare.